ArticleAnnals of medicine and surgery (2012)2025
Obstructive jaundice due to retroperitoneal desmoid-type fibromatosis: a case report and review of literature.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Desmoid-type fibromatosis (DF) is a rare, benign fibroblastic tumor arising from musculoaponeurotic structures. Despite lacking metastatic potential, it can be locally aggressive. Retroperitoneal DF is uncommon, and its presentation with obstructive jaundice is extremely rare. Case presentation: A 55-year-old male with no significant medical or family history presented with a six-month history of right upper quadrant abdominal pain and three weeks of progressive jaundice. Laboratory findings revealed a cholestatic pattern and elevated CA 19-9. Imaging, histopathological examination and immunohistochemistry were consistent with desmoid-type fibromatosis. The patient was managed with palliative chemotherapy and percutaneous transhepatic biliary drainage (PTBD) to relieve biliary obstruction. Clinical discussion: Retroperitoneal DF is typically managed with surgical excision or watchful waiting, depending on the location and symptoms. While surgical resection is preferred, it is often not feasible in cases involving extensive invasion. In this case, chemotherapy served as the primary treatment modality due to the tumor's unresectability. Conclusion: This case highlights the importance of including retroperitoneal desmoid-type fibromatosis in the differential diagnosis of obstructive jaundice and underscores the need for larger studies and updated management guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.